Security key
47010C854
Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX)
CUSIP: 47010C854
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 23
- Total 13F value
- $104
- Share change
- +23
- SEC-reported price per share
- $4.52
- Number of holders
- 1
- Value change
- +$104
- Number of buys
- 1
- Shares outstanding
- 1,898,068
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
1
Top holders
1
JAGX full security history
Ownership snapshot
Full 13F holder table
Jaguar Health, Inc. SEC filings
Jaguar Health, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 47010C854
Recent filing periods:
Ownership snapshot
Top reported holders of JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Joshua Mailman
Disclosed value leader
Lisa A. Conte
Comparable rows
5/15
Latest evidence
12 Sep 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
10 rows are not safely comparable across share classes.
13D/G row: Joshua Mailman
Showing 1-6 of 15 holder rows.
Quick read
Joshua Mailman leads the comparable SEC ownership view at 10%.
5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Joshua Mailman's linked filing trail.
Comparable ownership
Top 5
Joshua Mailman
10%
Uptown Capital, LLC
9.9%
Iliad Research & Trading, L.P.
9.8%
INTRACOASTAL CAPITAL, LLC
5%
CVI Investments, Inc.
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Joshua Mailman |
13D/G
|
10%
Reported 13D/G
· 12 Sep 2026
|
—
189,617 shares
|
$0 | 12 Sep 2026 |
| Uptown Capital, LLC |
13D/G
John Fife and Fredrick Waid
|
9.9%
Reported 13D/G
· 29 Jan 2025
|
$322,500
1,290,000 shares
|
$0 | 29 Jan 2025 |
| Iliad Research & Trading, L.P. |
13D/G
|
9.8%
Reported 13D/G
· 11 Dec 2025
|
$748,000
440,000 shares
|
$0 | 11 Dec 2025 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
Reported 13D/G
· 20 May 2025
|
$779,374
65,002 shares
|
$0 | 20 May 2025 |
| CVI Investments, Inc. |
13D/G
|
4.6%
Reported 13D/G
· 30 Sep 2025
|
$346,470
164,204 shares
|
+$36,300 | 30 Sep 2025 |
| Lincoln Alternative Strategies LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,284,000
600,000 shares
|
— | 28 Aug 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
23
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
0
Q3 2026 holders
1
Holder diff
1
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend